Market Value332,470,540
Total Holdings28
File Date2025-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RCKT / Rocket Pharmaceuticals, Inc.
ANAB / AnaptysBio, Inc.
GERN / Geron Corporation
PRLD / Prelude Therapeutics Incorporated
SRZNW / Surrozen, Inc. - Equity Warrant
TYRA / Tyra Biosciences, Inc.
XENE / Xenon Pharmaceuticals Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
BCAB / BioAtla, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
BOLD / Boundless Bio, Inc.
RNA / Atrium Therapeutics, Inc.
NUVL / Nuvalent, Inc.
APLS / Apellis Pharmaceuticals, Inc.
CMRX / Chimerix, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
ELVN / Enliven Therapeutics, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
MRSN / Mersana Therapeutics, Inc.
SRRK / Scholar Rock Holding Corporation
ARVN / Arvinas, Inc.
SYRE / Spyre Therapeutics, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
SWTX / SpringWorks Therapeutics, Inc.
RLAY / Relay Therapeutics, Inc.
SANA / Sana Biotechnology, Inc.
JSPR / Jasper Therapeutics, Inc.
PSTX / Poseida Therapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
CGEM / Cullinan Therapeutics, Inc.
KROS / Keros Therapeutics, Inc.
IMVT / Immunovant, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
AXSM / Axsome Therapeutics, Inc.
OBIO / Orchestra BioMed Holdings, Inc.
THRD / Third Harmonic Bio, Inc.
RCUS / Arcus Biosciences, Inc.
BCAX / Bicara Therapeutics Inc.
BDTX / Black Diamond Therapeutics, Inc.
ZURA / Zura Bio Limited
TERN / Terns Pharmaceuticals, Inc.
ITOS / iTeos Therapeutics, Inc.
PRTA / Prothena Corporation plc
CLYM / Climb Bio, Inc.
IOVA / Iovance Biotherapeutics, Inc.
RVMD / Revolution Medicines, Inc.
KALV / KalVista Pharmaceuticals, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
TIL / Instil Bio, Inc.
QURE / uniQure N.V.
MRUS / Merus N.V.
AMLX / Amylyx Pharmaceuticals, Inc.
KYMR / Kymera Therapeutics, Inc.
APGE / Apogee Therapeutics, Inc.
REPL / Replimune Group, Inc.
NRIX / Nurix Therapeutics, Inc.
SLDB / Solid Biosciences Inc.
TNGX / Tango Therapeutics, Inc.
MIST / Milestone Pharmaceuticals Inc.
DNLI / Denali Therapeutics Inc.
SMMT / Summit Therapeutics Inc.
KOD / Kodiak Sciences Inc.